Clinical Trial on Agitation in Alzheimer's Dementia
Trial details
- Registry ID
- NCT05543681
- Drugs studied
- IGC-AD1-Active
TrialRedline tracks 1 clinical trial sponsored by IGC Pharma, LLC: 1 Phase 2.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Clinical Trial on Agitation in Alzheimer's DementiaNCT05543681 | IGC-AD1-Active | Active not recruiting | 2026-11Estimated |
Names as written in the registry records.
NCT05543681 · IGC Pharma, LLC
Before: Aug 2026. After: Nov 2026.
Before: Recruiting. After: Active not recruiting.
NCT05543681 · IGC Pharma, LLC
Before: 30 Mar 2026. After: Aug 2026.